Even as the national economy manages to stay above water, the local picture is more complex. A number of states are starting to bounce back while other local economies remain under duress. Compared to a year ago, the employment picture has gotten even worse… Read More
David Sterman has worked as an investment analyst for nearly two decades. He started his Wall Street career in equity research at Smith Barney, culminating in a position as Senior Analyst covering European banks. While at Smith Barney, he learned of all the tricks used by Wall Street to steer the best advice to their top clients and their own trading desk. David has also served as Managing Editor at TheStreet.com and Director of Research at Individual Investor. In addition, David worked as Director of Research for Jesup & Lamont Securities. David has made numerous media appearances over the years, primarily on CNBC and Bloomberg TV, and has a master's degree in management from Georgia Tech. David Stermanon
Analyst Articles
A New Tech Revolution Could Lead to Triple Digit Gains for These Stocks
One of the mega growth companies of the past few years is Salesforce.com (NYSE : CRM). Since 2008, sales have spiked from $748.7 million to $1.3 billion. And investors have piled into the stock, which has gone from $34 to nearly $120 since early 2009. Salesforce.com builds… Read More
How China is Saving This Luxury Retail Icon
The economy stinks. More than a year after the worst recession since the Great Depression, the economy is sputtering again. Unemployment still hovers at 9.6% and the housing market continues to languish. Economic growth is so… Read More
One of Most Undervalued Sectors of the Market is Beginning to Rebound
In tough economic times, a high debt load can cripple a company. But when business is good, that debt can actually be a real benefit. That’s because equity comprises just a small part of the company’s total enterprise value (… Read More
7 Key Questions About Gold
Gold is on the march. The yellow metal is spiking to a new all time (non inflation-adjusted) highs of nearly $1,300 per ounce on renewed speculation that the Federal Reserve’s next moves will only strengthen the case for higher gold prices down the road. Let’s take a closer look at some key questions to see if gold is set to shine even brighter or eventually lose its luster. Q: What is the Fed concerned about? A: In its most recent statement after Federal Reserve Open Market Committee (FOMC)… Read More
Gold is on the march. The yellow metal is spiking to a new all time (non inflation-adjusted) highs of nearly $1,300 per ounce on renewed speculation that the Federal Reserve’s next moves will only strengthen the case for higher gold prices down the road. Let’s take a closer look at some key questions to see if gold is set to shine even brighter or eventually lose its luster. Q: What is the Fed concerned about? A: In its most recent statement after Federal Reserve Open Market Committee (FOMC) meetings, the Fed noted that potential deflation is of increasing concern. (Core annual inflation has been running at 0.9% for five months in a row, its lowest pace since 1966.) Any drop in prices could spell real trouble for the economy and would imperil borrowers that are seeing lower income but constant debt levels. Q: What might the Fed do? A: To help support prices, the Fed can inject money… Read More
A Possible +100% Return From a Company That’s Right Under Your Nose
I always keep my eyes open for investment opportunities. The best method is to literally keep them open when you are out and about doing your daily business. This is one of the ways I’ve found multi-bagger stocks over the years. Everyday items can certainly provide investors with good returns, but these companies tend to be what Peter Lynch called “stalwarts” — slow growing companies paying a nice dividend that should form the cornerstone of your portfolio. However, it is the companies behind the scenes or right under… Read More
I always keep my eyes open for investment opportunities. The best method is to literally keep them open when you are out and about doing your daily business. This is one of the ways I’ve found multi-bagger stocks over the years. Everyday items can certainly provide investors with good returns, but these companies tend to be what Peter Lynch called “stalwarts” — slow growing companies paying a nice dividend that should form the cornerstone of your portfolio. However, it is the companies behind the scenes or right under your nose that provide the big growth opportunities. Many years ago, I invested in a company called Flextronics (Nasdaq: FLEX). At the time, the company was providing a lot of the parts and electronics that went inside things like cellular phones. While I was in a Subway sandwich store a few weeks ago, I saw the employees rapidly heat up the sandwiches in a TurboChef oven. I thought a super-fast oven was a neat idea, but also dismayed to learn the company had been purchased in 2008 by Middleby Corporation (Nasdaq: MIDD), a company that designs, manufactures… Read More
If You Own One of These Popular High-Yielders, Pay Attention
My guess is you haven’t brought the Restoring American Financial Stability Act (the official name of the just-passed financial reform act) to the lake with you this summer. At 2,300 pages and filled with 100-word sentences written in complex legalese, the bill — signed into law with… Read More
This Dow Stock is Overvalued by at Least 25%
Cyclical stocks have always been tricky for investors. At the bottom of an economic cycle, they can appear to have fairly high price-to-earnings (P/E) ratios as investors look ahead to better times. When the cycle improves and approaches a peak, the P/E multiple… Read More
5 Chinese Stocks with Unlimited Potential
Investing in China has not been for the faint of heart. Shares of major companies have surged and fallen in repeating cycles during the past few years. But take a step back and note that China’s economic growth has only been going one way… Read More
Big Pharma’s Most Undervalued Stock
Large pharmaceutical companies have been ignored by investors for some time now. After decades of gangbuster growth and blockbuster drugs to treat depression, high blood pressure and many other common ailments, many are facing competition from generic drugs as the patents protecting the exclusive… Read More